Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets. Cosmos Health announced the Series 18 platform for commercialization in the US. The clinically validated products already introduced have an estimated addressable market size of $7.3 billion.
